Depression and failure of cholesterol lowering after acute myocardial infarction

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 12, Issue 1, 2010, Pages

  Huffman, Jeff C ^a,b   Smith, Felicia A ^a,b   Fricchione, Gregory L ^a,b   Januzzi, James L ^a,b   Nadelman, Sara ^a   Pirl, William F ^a,b  

^a Department of Psychiatry ^*  (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ACUTE HEART INFARCTION; AGE DISTRIBUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PILOT STUDY; PSYCHOLOGIC ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; STRUCTURED INTERVIEW;

EID: 78650487712     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.08m00766blu     Document Type: Article

References (17)

1. Saito D, Shiraki T, Oka T, et al. Rizsk factors indicating recurrent myocardial infarction after recovery from acute myocardial infarction. Circ J. 2002;66(10):877-880. doi:10.1253/circj.66.877
2. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350(15):1495-1504. doi:10.1056/NEJMoa040583
3. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66(6):814-822. doi:10.1097/01.psy.0000146294.82810.9c
4. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160(12):1818-1823. doi:10.1001/archinte.160.12.1818
5. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21(18):1502-1513. doi:10.1053/euhj.2000.2305
6. Williams JB, Gibbon M, First MB, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Washington, DC: American Psychiatric Press Inc; 1996.
7. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
8. Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297(4):367-379. doi:10.1001/jama.297.4.367
9. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701-709. doi:10.1001/jama.288.6.701
10. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66(3):411-421. doi:10.1097/01.psy.0000127692.23278.a9
11. Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry. 2006;51(12):738-745.
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
13. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339(19):1349-1357. doi:10.1056/NEJM199811053391902
14. Fadl YY, Krumholz HM, Kosiborod M, et al. Predictors of weight change in overweight patients with myocardial infarction. Am Heart J. 2007;154(4):711-717. doi:10.1016/j.ahj.2007.06.006
15. Lane D, Carroll D, Ring C, et al. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res. 2001;51(3):497-501. doi:10.1016/S0022-3999(01)00225-2
16. Glazer KM, Emery CF, Frid DJ, et al. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil. 2002;22(1):40-46. doi:10.1097/00008483-200201000-00006
17. McQuade R, Young AH. Future therapeutic targets in mood disorders: the glucocorticoid receptor. Br J Psychiatry. 2000;177:390-395. doi:10.1192/bjp.177.5.390